From the Critical Care Department (DK, AA), Attikon University Hospital, Athens, Greece; Rovira i Virgili University (DK, TL, JR), Tarragona, Spain; Critical Care Department (TL, ED, JR), Joan XXIII University Hospital–Pere Virgili Health Institut and CIBER Enfermedades Respiratorias (CIBERES), Tarragona, Spain; Critical Care Department (CBB), Henri Mondor University Hospital, Paris, France; Department of Anaesthesiology and Intensive Care Medicine (WK), Tuebingen University Hospital, Tuebingen and Constance Hospital, Constance, Germany; Department of Infectious Risk Prevention (AM), Amedeo di Savoia Hospital, Torino, Italy; Critical Care Department (JSV), Dr Negrin University Hospital, Gran Canaria, Spain; Critical Care Department (AT), Hacettepe University Hospital, Ankara, Turkey; Critical Care Department (JD), Ghent University Hospital, Ghent, Belgium; Critical Care Department (AC), Santo Antonio Hospital, Porto, Portugal; and Critical Care Department (IML), Mater Misericordiae University Hospital, Dublin, Ireland. Members of the EU-VAP/CAP Study Group are listed in Appendix 1 (Collaborators).
Supported, in part, by Generalitat de Catalunya grant SGR 05/920, by CIBER Enfermedades Respiratorias (CIBERES), and by Carlos III Health Institute grants PI05/2410 and AI/07/90031.
Presented, in part, at the American Thoracic Society International Conference, Toronto, Ontario, May 16–21, 2008, and at the European Society of Intensive Care Medicine Congress, Lisbon, Portugal, September 21–24, 2008.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML and PDF versions of this article on the journal's Web site (www.ccmjournal.org).
The authors have not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]